Deciphering the Therapeutic Mechanisms of Wuzi Yanzong Pill for Asthenozoospermia: A Synergistic Approach Combining Bioinformatics and Molecular Dynamics
- PMID: 40783635
- DOI: 10.1007/s12013-025-01835-x
Deciphering the Therapeutic Mechanisms of Wuzi Yanzong Pill for Asthenozoospermia: A Synergistic Approach Combining Bioinformatics and Molecular Dynamics
Abstract
Wuzi Yanzong Pill (WZYZP) is a traditional Chinese medicine formula extensively used in China to treat male reproductive dysfunction, with a specific focus on invigorating the kidney. Despite its observed efficacy, the exact mechanisms and therapeutic targets remain unclear. The primary goal of this study is to elucidate the potential molecular targets and underlying mechanisms of WZYZP in the treatment of asthenozoospermia (AZS). It will be achieved through the integration of network pharmacology and bioinformatics analyses in a comprehensive and systematic approach. This study employed bioinformatics analysis and network pharmacology methodologies, encompassing: construction of protein-protein interaction (PPI) networks; development of 'Ingredients-Potential Target Genes-Signaling Pathways' (IPS) networks; Gene Ontology (GO) functional annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis; differential gene analysis; molecular docking; and molecular dynamics simulations (MDS). Through network pharmacology analysis, we identified 485 potential targets of WZYZP. Cross-referencing with disease databases resulted in 57 intersecting targets pertinent to both WZYZP and AZS. Construction of the IPS network further determined eight core candidate targets: PIK3R1, MAPK3, GSK3B, AKT1, MAPK14, ESR1, ESR2, and CYP17A1. GO and KEGG pathway enrichment analyses highlighted significant involvement in prolactin signaling, endocrine resistance, and estrogen signaling pathways. Molecular docking and MDS confirmed stable binding of WZYZP components to all eight core targets. Our findings suggest that WZYZP may exert therapeutic effects in AZS by targeting eight pivotal genes (PIK3R1, MAPK3, GSK3B, AKT1, MAPK14, ESR1, ESR2, and CYP17A1). This is achieved through modulation of prolactin signaling, estrogen signaling, and endocrine resistance, thereby inhibiting inflammatory damage, antagonizing apoptotic signaling, maintaining hormonal homeostasis, and restoring metabolic imbalance.
Keywords: Asthenozoospermia; Molecular dynamics; Network pharmacology; Wuzi Yanzong pill.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Compliance with ethical standards. Conflict of interest: The authors declare no competing interests.
Similar articles
-
Elucidating the Mechanism of Xiaoqinglong Decoction in Chronic Urticaria Treatment: An Integrated Approach of Network Pharmacology, Bioinformatics Analysis, Molecular Docking, and Molecular Dynamics Simulations.Curr Comput Aided Drug Des. 2025 Jul 16. doi: 10.2174/0115734099391401250701045509. Online ahead of print. Curr Comput Aided Drug Des. 2025. PMID: 40676786
-
Sheng-ji Hua-yu Formula promotes diabetic ulcer healing via regulating the cAMP/PKA/CREB signaling pathway.J Ethnopharmacol. 2025 Jul 24;351:120105. doi: 10.1016/j.jep.2025.120105. Epub 2025 Jun 6. J Ethnopharmacol. 2025. PMID: 40484258
-
Multi-target Mechanisms of Si-Ni-San on Anxious Insomnia: An Example of Network-pharmacology and Molecular Docking Analysis.Curr Med Chem. 2025;32(13):2640-2663. doi: 10.2174/0109298673299665240924090617. Curr Med Chem. 2025. PMID: 39410900 Free PMC article.
-
Medicine for chronic atrophic gastritis: a systematic review, meta- and network pharmacology analysis.Ann Med. 2023;55(2):2299352. doi: 10.1080/07853890.2023.2299352. Epub 2024 Jan 3. Ann Med. 2023. PMID: 38170849 Free PMC article.
-
Study on the mechanism of Shujin Tongluo granules in treating cervical spondylosis based on network pharmacology and molecular docking.Medicine (Baltimore). 2023 Jul 21;102(29):e34030. doi: 10.1097/MD.0000000000034030. Medicine (Baltimore). 2023. PMID: 37478234 Free PMC article.
References
-
- Eisenberg, M. L., Esteves, S. C., Lamb, D. J., Hotaling, J. M., Giwercman, A., Hwang, K., & Cheng, Y. S. (2023). Male infertility. Nature Reviews Disease Primers, 9(1), 49. https://doi.org/10.1038/s41572-023-00459-w . - DOI - PubMed
-
- De Jonge, C., & Barratt, C. L. R. (2019). The present crisis in male reproductive health: an urgent need for a political, social, and research roadmap. Andrology, 7(6), 762–768. https://doi.org/10.1111/andr.12673 . - DOI - PubMed
-
- Minhas, S., Bettocchi, C., Boeri, L., Capogrosso, P., Carvalho, J., Cilesiz, N. C., Cocci, A., Corona, G., Dimitropoulos, K., Gül, M., Hatzichristodoulou, G., Jones, T. H., Kadioglu, A., Martínez Salamanca, J. I., Milenkovic, U., Modgil, V., Russo, G. I., Serefoglu, E. C., Tharakan, T., & EAU working group on male sexual and reproductive health. (2021). European association of urology guidelines on male sexual and reproductive health: 2021 update on male infertility. European Urology, 80(5), 603–620. https://doi.org/10.1016/j.eururo.2021.08.014 . - DOI - PubMed
-
- Paffoni, A., Somigliana, E., Boeri, L., & Viganò, P. (2022). The statistical foundation of the reference population for semen analysis included in the sixth edition of the WHO manual: a critical reappraisal of the evidence. Human Reproduction, 37(10), 2237–2245. https://doi.org/10.1093/humrep/deac161 . - DOI - PubMed - PMC
-
- Boguenet, M., Bouet, P. E., Spiers, A., Reynier, P., & May-Panloup, P. (2021). Mitochondria: their role in spermatozoa and in male infertility. Human Reproduction Update, 27(4), 697–719. https://doi.org/10.1093/humupd/dmab001 . - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous